269 related articles for article (PubMed ID: 28846212)
1. Donation after cardiac death in the hepatocellular carcinoma patient: Same indication?
Vining CC; Ecker BL; Abt PL; Olthoff KM
Liver Transpl; 2017 Oct; 23(S1):S27-S33. PubMed ID: 28846212
[No Abstract] [Full Text] [Related]
2. Living Donor Versus Deceased Donor Liver Transplantation for HCC.
Doğan SM; Kutlutürk K
J Gastrointest Cancer; 2020 Dec; 51(4):1104-1106. PubMed ID: 32833221
[TBL] [Abstract][Full Text] [Related]
3. Outcomes utilizing imported liver grafts for recipients with hepatocellular carcinoma.
Battula N; Reichman TW; Amiri Y; Carmody IC; Galliano G; Seal J; Bugeaud E; Bohorquez H; Bruce D; Cohen A; Loss GE
Liver Transpl; 2017 Mar; 23(3):299-304. PubMed ID: 28026108
[TBL] [Abstract][Full Text] [Related]
4. Effect of Mandatory 6-Month Waiting Period on Waitlist and Transplant Outcomes in Patients With Hepatocellular Carcinoma.
Nagai S; Kitajima T; Yeddula S; Salgia R; Schilke R; Abouljoud MS; Moonka D
Hepatology; 2020 Dec; 72(6):2051-2062. PubMed ID: 32157711
[TBL] [Abstract][Full Text] [Related]
5. Increasing Liver Transplantation Wait-List Dropout for Hepatocellular Carcinoma With Widening Geographical Disparities: Implications for Organ Allocation.
Mehta N; Dodge JL; Hirose R; Roberts JP; Yao FY
Liver Transpl; 2018 Oct; 24(10):1346-1356. PubMed ID: 30067889
[TBL] [Abstract][Full Text] [Related]
6. Model for end-stage liver disease exceptions: proceed with caution.
Washburn K
Liver Transpl; 2011 Oct; 17(10):1123-4. PubMed ID: 21837739
[No Abstract] [Full Text] [Related]
7. Liver Transplantation for Hepatic Epithelioid Hemangioendothelioma Is Facilitated by Exception Points With Acceptable Long-term Outcomes.
Brahmbhatt M; Prenner S; Bittermann T
Transplantation; 2020 Jun; 104(6):1187-1192. PubMed ID: 31577674
[TBL] [Abstract][Full Text] [Related]
8. MELDEQ : An alternative Model for End-Stage Liver Disease score for patients with hepatocellular carcinoma.
Marvin MR; Ferguson N; Cannon RM; Jones CM; Brock GN
Liver Transpl; 2015 May; 21(5):612-22. PubMed ID: 25694099
[TBL] [Abstract][Full Text] [Related]
9. Predictors of low risk for dropout from the liver transplant waiting list for hepatocellular carcinoma in long wait time regions: Implications for organ allocation.
Mehta N; Dodge JL; Hirose R; Roberts JP; Yao FY
Am J Transplant; 2019 Aug; 19(8):2210-2218. PubMed ID: 30861298
[TBL] [Abstract][Full Text] [Related]
10. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
[TBL] [Abstract][Full Text] [Related]
11. Disparities in Liver Transplantation Resulting From Variations in Regional Donor Supply and Multiple Listing Practices.
Cholankeril G; Yoo ER; Perumpail RB; Younossi ZM; Ahmed A
Clin Gastroenterol Hepatol; 2017 Feb; 15(2):313-315. PubMed ID: 27609705
[No Abstract] [Full Text] [Related]
12. Liver transplantation in Germany.
Tacke F; Kroy DC; Barreiros AP; Neumann UP
Liver Transpl; 2016 Aug; 22(8):1136-42. PubMed ID: 27082951
[TBL] [Abstract][Full Text] [Related]
13. Top ten facts you need to know: about liver transplantation.
Butt FK; Earl TM; Anderson CD
J Miss State Med Assoc; 2014 Jul; 55(7):212-5. PubMed ID: 25252424
[No Abstract] [Full Text] [Related]
14. Liver transplantation for hepatocellular carcinoma: is expansion of criteria justified?
Roayaie S; Llovet JM
Clin Liver Dis; 2005 May; 9(2):315-28. PubMed ID: 15831276
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablation of hepatocellular carcinoma as bridge therapy to liver transplantation: A 10-year intention-to-treat analysis.
Lee MW; Raman SS; Asvadi NH; Siripongsakun S; Hicks RM; Chen J; Worakitsitisatorn A; McWilliams J; Tong MJ; Finn RS; Agopian VG; Busuttil RW; Lu DSK
Hepatology; 2017 Jun; 65(6):1979-1990. PubMed ID: 28170115
[TBL] [Abstract][Full Text] [Related]
16. [Selection criteria decisive in hepatocellular carcinoma].
Söderdahl G; Eilard MS; Rizell M
Lakartidningen; 2012 Sep 26-Oct 9; 109(39-40):1750-3. PubMed ID: 23097883
[No Abstract] [Full Text] [Related]
17. Shorter Height Is Associated With Lower Probability of Liver Transplantation in Patients With Hepatocellular Carcinoma.
Lee E; Sarkar M; Dodge J; Kohi M; Mehta N
Transplantation; 2020 May; 104(5):988-995. PubMed ID: 31577670
[TBL] [Abstract][Full Text] [Related]
18. Liver Transplantation in France.
Durand F; Antoine C; Soubrane O
Liver Transpl; 2019 May; 25(5):763-770. PubMed ID: 30697904
[TBL] [Abstract][Full Text] [Related]
19. Toward optimizing the indications for orthotopic liver transplantation in hepatocellular carcinoma.
Samuel D; Colombo M; El-Serag H; Sobesky R; Heaton N
Liver Transpl; 2011 Oct; 17 Suppl 2():S6-13. PubMed ID: 21858912
[TBL] [Abstract][Full Text] [Related]
20. Current Status of Simultaneous Liver-Kidney Transplantation in the United States.
Lum EL; Cárdenas A; Martin P; Bunnapradist S
Liver Transpl; 2019 May; 25(5):797-806. PubMed ID: 30861294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
